CDT Equity CDT
NASDAQ CDT
$2.86 -0.04 (-1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

CDT Equity (CDT) Convertible Debt (2022 - 2024)

CDT Equity's (CDT) quarterly Convertible Debt came in at $800000.0 in Q4 2024, little changed YoY from $800000.0 in Q1 2024, and little changed on a QoQ basis from $800000.0 in Q3 2024.

CDT Equity (CDT) Convertible Debt (2022 - 2024) Analysis & Trends

CDT Equity (CDT) has 3 years of Convertible Debt data on file, last reported at $800000.0 in Q4 2024.

  • Quarterly Convertible Debt changed 0.0% year-over-year to $800000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $800000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $800000.0, changed 0.0% from the prior year.
  • Convertible Debt held at $800000.0 in Q4 2024, from $800000.0 in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $1.8 million in Q4 2022 to a low of $800000.0 in Q4 2023.
  • A 3-year average of $1.0 million and a median of $800000.0 in 2023 frame the typical range for Convertible Debt.
  • Annual changes were most pronounced in 2023 — Convertible Debt tumbled 56.4% — and 2024, when it changed 0.0%.
  • Tracing CDT's Convertible Debt over 3 years: stood at $1.8 million in 2022, then plunged by 56.4% to $800000.0 in 2023, then changed by 0.0% to $800000.0 in 2024.
  • The last three Convertible Debt figures came in at $800000.0 (Q4 2024), $800000.0 (Q3 2024), and $800000.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 CDT Equity 1.55 Mn 1.55 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 800,000.00
Sep 30, 2024 800,000.00
Jun 30, 2024 800,000.00
Dec 31, 2023 800,000.00
Dec 31, 2022 1.84 Mn